Dumo, Lyca M.

HRN: 26-36-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
CEFUROXIME 750MG (VIAL)
03/20/2026
03/27/2026
IV
750mg
Q 8 Hours
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: